Exploring PRM-A as a novel glycan-targeted therapy for SARS-CoV-2 inhibition

Exploring PRM-A as a novel glycan-targeted therapy for SARS-CoV-2 inhibition
HIV, Ebola and most recently, COVID-19 viruses have had an enormous impact on our societies world-wide.
HIV, Ebola and most recently, COVID-19 viruses have had an enormous impact on our societies world-wide. All these viruses are 'enveloped viruses,' viruses that ... Read More



Related Stories

See All